written by reader Dylan Jovine claims the next big biotech takeover in 2020 will be a” Cut and Paste” company

By backoffice, March 21, 2020

along the line of CRISPR. There are 3 stocks that fit that category from CRSP. EDIT, and NTLA. Anyone have an idea which one he’s talking about? Thanks

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

2 Comments
Inline Feedbacks
View all comments
Travis Johnson, Stock Gumshoe
March 23, 2020 3:08 pm

That ad has been running for a long time now, but it’s Editas… covered here most recently:

https://www.stockgumshoe.com/reviews/behind-the-markets/whats-this-living-software-business-from-dylan-jovine/

Add a Topic
5211
Add a Topic
160
👍 16004
OSUfball
Irregular
April 18, 2020 1:33 pm

The email blast he’s been sending out this month for a cancer company treating lymphoma that “could save your life” is MEI Pharma (MEIP). It was not hard for me to figure out with the clues he gave, most notably, MEI received FDA fast track approval in early April and recently received a $100M investment from a foreign pharma.

👍 298

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info